Today: 9 April 2026
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings
7 January 2026
1 min read

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

New York, Jan 7, 2026, 17:15 EST — After-hours

UnitedHealth Group Inc (UNH) shares fell about 2% to $341.70 in after-hours trading on Wednesday, after sliding through the close. The stock ranged from $338.11 to $349.55 during the session, leaving traders watching whether the late-day low holds into Thursday.

The pullback comes as investors look for signs the company is trimming edges ahead of its next guidance. Sky News reported on Tuesday that private equity firm TPG is close to buying Optum UK for between 1.2 billion pounds and 1.4 billion pounds ($1.62 billion to $1.89 billion), with Bank of America advising on the process. Optum UK supplies electronic patient record systems to most British general practitioners, the report said, adding the talks could still fall apart. Reuters

UnitedHealth had climbed about 3% on Tuesday, one of the biggest boosts to the Dow, before giving some of that back as the index weakened on Wednesday. With the Jan. 27 report nearing, the market is trying to pin down a simpler question: are medical costs easing, and can Optum’s margins stabilize enough for a cleaner 2026 outlook. marketwatch.com

Analyst notes have leaned more constructive into the earnings setup. Barclays analyst Andrew Mok on Monday raised his price target on UnitedHealth to $391 from $386 and kept an “overweight” rating, meaning he expects the shares to outperform the average in his coverage. Mok said managed-care names — health insurers that manage costs through contracted provider networks — could benefit in 2026 from margin expansion and a rotation toward “de-rated underperformers.” TipRanks

Peers moved in the same direction on Wednesday, keeping the sector tone heavy. Cigna slipped about 2% and CVS Health and Elevance Health also fell as the broader market ended lower. marketwatch.com

UnitedHealth will release full-year 2025 results and provide 2026 financial guidance on Tuesday, Jan. 27, before the market opens, and will host a conference call at 8 a.m. ET, the company said. Investors typically focus on the medical care ratio — the share of premiums spent on medical claims — along with Optum’s service margins and any detail on pricing and cost controls. UnitedHealth Group

Macro data also tightened risk appetite late in the day. U.S. job openings fell to a 14-month low in November, and an ADP report showed private hiring rose modestly in December; “jobs were gained in December, but at a relatively slow pace,” High Frequency Economics chief economist Carl Weinberg said. Reuters

But the bigger swing factor for UnitedHealth is still utilization. If doctor and hospital visits stay elevated, management’s 2026 outlook could land soft, and a potential Optum UK deal would not change that quickly.

Next up, traders get U.S. productivity data on Thursday, the December jobs report on Friday and December CPI on Jan. 13 — all inputs for rate expectations before UnitedHealth reports. The Federal Reserve meets Jan. 27-28, the same week UnitedHealth is set to lay out its 2026 guidance. Bureau of Labor Statistics+1

Stock Market Today

  • Thomson Reuters (TRI) Upgraded to Buy on Rising Earnings Estimates
    April 9, 2026, 2:13 PM EDT. Thomson Reuters (TRI) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, a key factor influencing stock price movements. The Zacks rating, based solely on changes in earnings potential, signals an improved business outlook. This upgrade reflects growing confidence among institutional investors, who adjust share valuations based on earnings revisions, leading to potential stock price gains. The company is expected to earn $4.40 per share for the fiscal year ending December 2026, in line with last year. This upgrade highlights the importance of tracking earnings estimate revisions as a strategy for investment decisions in the near term.

Latest article

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

9 April 2026
The Dow Jones rose 247.66 points to 48,155.97 by midday Thursday, following a surge linked to signs of Middle East de-escalation and Israeli plans for peace talks with Lebanon. Oil prices fell over $4 a barrel after Netanyahu’s remarks, but remain 40% above pre-conflict levels. Amazon climbed 4.3% on strong AI revenue. Traders now see only a 30% chance of a Fed rate cut by year-end, down from 56%.
US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

9 April 2026
The Dow rose 337 points, or 0.7%, by 1 p.m. Thursday as oil prices retreated after Israel announced direct talks with Lebanon and hopes for a U.S.-Iran ceasefire steadied markets. Amazon shares climbed on news its AWS AI services topped $15 billion in annualized revenue. The Fed signaled possible rate hikes if inflation persists. Oil shipments through the Strait of Hormuz remained sharply reduced.
Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27
Previous Story

Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27

AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’
Next Story

AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’

Go toTop